Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients.
Cheng TC, Hung MC, Wang LH, Tu SH, Wu CH, Yen Y, Chen CL, Whang-Peng J, Lee WJ, Liao YC, Lee YC, Pan MH, Lin HK, Tzeng HE, Guo P, Chu CY, Chen LC, Ho YS.
Cheng TC, et al. Among authors: wu ch.
Biomark Res. 2025 Jan 9;13(1):7. doi: 10.1186/s40364-024-00715-5.
Biomark Res. 2025.
PMID: 39789599
Free article.